Patents by Inventor Antoine LaFont

Antoine LaFont has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • MAMMALIAN CELL POPULATION AND MEDICAMENTS FOR CELL THERAPIES IN HUMANS AND IMPROVED CELL CULTIVATION METHODS
    Publication number: 20240309323
    Abstract: Compositions of matter, including cell populations and medicaments, are provided that are derived from human gingival fibroblasts and have cell phenotypes that occur in proportions not found in natural gum tissue, but rather, are preferentially are selected to express proteins favoring angiogenesis and anti-inflammatory effects, while reducing cell populations that promote tumorigenicity and/or formation of metalloproteinases that inhibit tissue regeneration. Methods of generating such compositions are provided that increase proliferation many-fold compared to previously known methods, and methods of using such compositions in a wide range of human cell therapies are provided.
    Type: Application
    Filed: April 17, 2023
    Publication date: September 19, 2024
    Applicant: SCARCELL Therapeutics
    Inventors: Antoine LAFONT, Mathieu CASTELA
  • MAMMALIAN CELL POPULATION AND MEDICAMENTS FOR CELL THERAPIES IN EQUINES AND IMPROVED CELL CULTIVATION METHODS
    Publication number: 20240307454
    Abstract: Compositions of matter, including cell populations and medicaments, are provided that are derived from equine gingival fibroblasts and have cell phenotypes that occur in proportions not found in natural gum tissue, but rather, are preferentially are selected to express proteins favoring angiogenesis and anti-inflammatory effects, while reducing cell populations that promote tumorigenicity and/or formation of metalloproteinases that inhibit tissue regeneration. Methods of generating such compositions are provided that increase proliferation many-fold compared to previously known methods, and methods of using such compositions in a wide range of equine cell therapies are provided.
    Type: Application
    Filed: April 17, 2023
    Publication date: September 19, 2024
    Applicant: SCARCELL Therapeutics
    Inventors: Antoine LAFONT, Mathieu CASTELA
  • MAMMALIAN CELL POPULATION AND MEDICAMENTS FOR CELL THERAPIES IN CANINES AND IMPROVED CELL CULTIVATION METHODS
    Publication number: 20240307456
    Abstract: Compositions of matter, including cell populations and medicaments, are provided that are derived from canine gingival fibroblasts and have cell phenotypes that occur in proportions not found in natural gum tissue, but rather, are preferentially are selected to express proteins favoring angiogenesis and anti-inflammatory effects, while reducing cell populations that promote tumorigenicity and/or formation of metalloproteinases that inhibit tissue regeneration. Methods of generating such compositions are provided that increase proliferation many-fold compared to previously known methods, and methods of using such compositions in a wide range of canine cell therapies are provided.
    Type: Application
    Filed: April 17, 2023
    Publication date: September 19, 2024
    Applicant: SCARCELL Therapeutics
    Inventors: Antoine LAFONT, Mathieu CASTELA
  • Compositions useful for the treatment of immune-related diseases
    Patent number: 11229670
    Abstract: The present invention relates to a gingival fibroblast-derived product for use in the treatment or prevention of an immune-related disease in an individual.
    Type: Grant
    Filed: November 18, 2017
    Date of Patent: January 25, 2022
    Assignee: SCARCELL THERAPEUTICS
    Inventors: Antoine Lafont, Bernard Coulomb
  • Use of gingival fibroblasts in the treatment of alopecia
    Publication number: 20200306174
    Abstract: The present invention relates to the use of gingival fibroblast-derived products to reduce hair loss and promote hair growth. Specifically, the invention relates to a product derived from gingival fibroblasts to be used in the treatment or prevention of alopecia, as well as in the promotion of natural hair growth and/or in the control of natural hair loss.
    Type: Application
    Filed: April 20, 2020
    Publication date: October 1, 2020
    Inventors: Antoine LAFONT, Bernard COULOMB, Jean-Jacques LATAILLADE, Christine LINARD
  • COMPOSITION FOR THE TREATMENT OF A MUSCULOSKELETAL DISEASE
    Publication number: 20200268805
    Abstract: The present invention relates to a composition comprising buccal cells for use in the prevention or treatment of musculoskeletal diseases in horses.
    Type: Application
    Filed: October 25, 2017
    Publication date: August 27, 2020
    Inventors: Antoine LAFONT, Bernard COULOMB
  • Use of gingival fibroblasts in the treatment of alopecia
    Patent number: 10624838
    Abstract: The present invention relates to the use of gingival fibroblast-derived products to reduce hair loss and promote hair growth. Specifically, the invention relates to a product derived from gingival fibroblasts to be used in the treatment or prevention of alopecia, as well as in the promotion of natural hair growth and/or in the control of natural hair loss.
    Type: Grant
    Filed: July 9, 2014
    Date of Patent: April 21, 2020
    Assignees: ASSISTANCE PUBLIQUE—HOPITAUX DE PARIS, INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE (INSERM), INSTITUT DE RADIOPROTECTION ET DE SURETE NUCLEAIRE, ETAT FRANCAIS—MINISTERE DE AL DEFENSE—DIRECTION CENTRALE DU SERVICE DE SANTE DES ARMEES, UNIVERSITE PARIS DESCARTES
    Inventors: Antoine Lafont, Bernard Coulomb, Jean-Jacques Lataillade, Christine Linard
  • COMPOSITIONS USEFUL FOR THE TREATMENT OF IMMUNE-RELATED DISEASES
    Publication number: 20190269736
    Abstract: The present invention relates to a gingival fibroblast-derived product for use in the treatment or prevention of an immune-related disease in an individual.
    Type: Application
    Filed: November 18, 2017
    Publication date: September 5, 2019
    Inventors: Antoine LAFONT, Bernard COULOMB
  • METHOD FOR TREATING CANCER
    Publication number: 20180028571
    Abstract: The present invention relates to a method for preventing or treating cancer in an individual comprising administering the individual with a prophylactically or therapeutically effective quantity of a gingival fibroblast-derived product.
    Type: Application
    Filed: October 12, 2017
    Publication date: February 1, 2018
    Inventors: Bruno GOGLY, Antoine LAFONT, Bernard COULOMB, Jean-Jacques LATAILLADE
  • Device for administering cells and cell-therapy methods using said device
    Patent number: 9867971
    Abstract: The present invention relates to a device (2) for cell therapy, said device being designed to be applied on a living tissue and having at least a tight preferably biocompatible first wall (22), designed to form a cavity (24) between said wall and said tissue, and further comprising means (7) to feed a healing substance in said cavity.
    Type: Grant
    Filed: October 9, 2008
    Date of Patent: January 16, 2018
    Assignees: ASSISTANCE PUBLIQUE—HOPITAUX DE PARIS, INSERM, UNIVERSITE PARIS DESCARTES
    Inventors: Bruno Gogly, Bernard Coulomb, Antoine Lafont
  • PHARMACEUTICAL COMPOSITION AND METHOD FOR THE TREATMENT OF ORTHOPEDIC PATHOLOGIES
    Publication number: 20160256496
    Abstract: The present invention relates to a gingival fibroblast-derived product and its use in methods for the prevention or treatment of orthopedic pathologies in an individual.
    Type: Application
    Filed: March 4, 2016
    Publication date: September 8, 2016
    Inventors: Bruno GOGLY, Antoine LAFONT, Bernard COULOMB
  • METHOD FOR TREATING CANCER
    Publication number: 20160158290
    Abstract: The present invention relates to a method for preventing or treating cancer in an individual comprising administering the individual with a prophylactically or therapeutically effective quantity of a gingival fibroblast-derived product.
    Type: Application
    Filed: February 17, 2016
    Publication date: June 9, 2016
    Inventors: Bruno GOGLY, Antoine LAFONT, Bernard COULOMB, Jean-Jacques LATALLIADE
  • Use of gingival fibroblasts in the treatment of alopecia
    Publication number: 20160151274
    Abstract: The present invention relates to the use of gingival fibroblasts-derived products to reduce hair loss and promote hair growth. Specifically, the invention relates to a product derived from gingival fibroblasts to be used in the treatment or prevention of alopecia, as well as in the promotion of natural hair growth and/or in the control of natural hair loss.
    Type: Application
    Filed: July 9, 2014
    Publication date: June 2, 2016
    Inventors: Antoine LAFONT, Bernard COULOMB, Jean-Jacques LATAILLADE, Christine LINARD
  • Polymer-based stent assembly
    Patent number: 9283094
    Abstract: Methods for preparing a polymer-based stent assembly comprising an inflatable balloon catheter and a polymer-based stent resistant to relaxation-related negative recoil are provided.
    Type: Grant
    Filed: April 21, 2010
    Date of Patent: March 15, 2016
    Assignee: Arterial Remodelling Technologies, Inc.
    Inventors: Antoine LaFont, Serge Piranda, Patrick Sabaria, Tahmer Sharkawi, Michel Vert
  • PHARMACEUTICAL COMPOSITION FOR THE TREATMENT OF ORTHOPEDIC PATHOLOGIES
    Publication number: 20150258146
    Abstract: The present invention relates to a gingival fibroblast-derived product for use in the prevention or treatment of orthopedic pathologies in an individual.
    Type: Application
    Filed: December 10, 2010
    Publication date: September 17, 2015
    Applicant: SCARCELL THERAPEUTICS
    Inventors: Bruno Gogly, Antoine Lafont, Bernard Coulomb
  • Use of gingival fibroblasts for vascular cell therapy
    Patent number: 8609085
    Abstract: The invention relates to the use of gingival fibroblasts for obtaining a cellular composition for treating arterial-remodelling pathology, for example an aneurysm, post-cryoplasty stenosis and restenosis, an aortic dissection or atherosclerosis.
    Type: Grant
    Filed: January 6, 2012
    Date of Patent: December 17, 2013
    Assignees: Universite Paris Decartes, L'assistance Publique—Hopitaux de Paris
    Inventors: Antoine Lafont, Bruno Gogly
  • Method for treating skin wounds
    Patent number: 8303948
    Abstract: The present invention relates to a method for treating a skin wound in an individual, comprising applying to the skin wound of the individual a therapeutically effective quantity of gingival fibroblasts.
    Type: Grant
    Filed: August 7, 2007
    Date of Patent: November 6, 2012
    Assignees: Universite Paris Descartes, Institut National de la Sante et de la Recherche Medicale (INSERM), Assistance Publique—Hopitaux de Paris
    Inventors: Bruno Gogly, Bernard Coulomb, Antoine Lafont
  • USE OF GINGIVAL FIBROBLASTS FOR VASCULAR CELL THERAPY
    Publication number: 20120177613
    Abstract: The invention relates to the use of gingival fibroblasts for obtaining a cellular composition for treating arterial-remodelling pathology, for example an aneurysm, post-cryoplasty stenosis and restenosis, an aortic dissection or atherosclerosis.
    Type: Application
    Filed: January 6, 2012
    Publication date: July 12, 2012
    Applicants: L'assistance Publique - Hopitaux De Paris, Universite Rene Descartes (Paris V)
    Inventors: Antoine Lafont, Bruno Gogly
  • METHOD FOR TREATING CANCER
    Publication number: 20120100111
    Abstract: The present invention relates to a method for preventing or treating cancer in an individual comprising administering the individual with a prophylactically or therapeutically effective quantity of a gingival fibroblast-derived product.
    Type: Application
    Filed: March 8, 2010
    Publication date: April 26, 2012
    Applicant: UNIVERSITE PARIS DESCARTES
    Inventors: Bruno Gogly, Antoine Lafont, Bernard Coulomb, Jean-Jacques Lataillade
  • Use of gingival fibroblasts for vascular cell therapy
    Patent number: 8119122
    Abstract: The invention relates to the use of gingival fibroblasts for obtaining a cellular composition for treating arterial-remodelling pathology, for example an aneurysm, post-cryoplasty stenosis and restenosis, an aortic dissection or atherosclerosis.
    Type: Grant
    Filed: July 1, 2005
    Date of Patent: February 21, 2012
    Assignees: Universite Paris Decartes, L'Assistance Publique-Hopitaux De Paris
    Inventors: Antoine Lafont, Bruno Gogly